Alterations of redox dynamics and desmin post-translational modifications in skeletal muscle models of desminopathies.

[1]  A. Ferreiro,et al.  Muscle redox disturbances and oxidative stress as pathomechanisms and therapeutic targets in early-onset myopathies. , 2017, Seminars in cell & developmental biology.

[2]  S. Batonnet-Pichon,et al.  Myofibrillar Myopathies: New Perspectives from Animal Models to Potential Therapeutic Approaches , 2017, Journal of neuromuscular diseases.

[3]  M. Ristow,et al.  Do antioxidant supplements interfere with skeletal muscle adaptation to exercise training? , 2016, The Journal of physiology.

[4]  S. Powers,et al.  Exercise‐induced oxidative stress: past, present and future , 2016, The Journal of physiology.

[5]  G. McConell,et al.  Muscle redox signalling pathways in exercise. Role of antioxidants. , 2016, Free radical biology & medicine.

[6]  R. Kley,et al.  Mutant desmin substantially perturbs mitochondrial morphology, function and maintenance in skeletal muscle tissue , 2016, Acta Neuropathologica.

[7]  P. Amouyel,et al.  Increased level of phosphorylated desmin and its degradation products in heart failure , 2016, Biochemistry and biophysics reports.

[8]  G. Faulkner,et al.  Immunoblot as a potential diagnostic tool for myofibrillar myopathies , 2015, Electrophoresis.

[9]  S. Batonnet-Pichon,et al.  Antioxidant Treatment and Induction of Autophagy Cooperate to Reduce Desmin Aggregation in a Cellular Model of Desminopathy , 2015, PloS one.

[10]  J. Laporte,et al.  Desmin in muscle and associated diseases: beyond the structural function , 2015, Cell and Tissue Research.

[11]  E. Bertini,et al.  G.P.209 N-acetylcysteine as an effective treatment in vivo and identification of biomarkers in SEPN1-related myopathy: A first preclinical trial , 2014, Neuromuscular Disorders.

[12]  F. Huang,et al.  Influence of oxidation on the susceptibility of purified desmin to degradation by μ-calpain, caspase-3 and -6. , 2014, Food chemistry.

[13]  W. H. Goldmann,et al.  Chemical chaperone ameliorates pathological protein aggregation in plectin-deficient muscle. , 2014, The Journal of clinical investigation.

[14]  M. Omary,et al.  Post-translational modifications of intermediate filament proteins: mechanisms and functions , 2014, Nature Reviews Molecular Cell Biology.

[15]  S. Simon,et al.  N-Acetyl-L-Cysteine Prevents Stress-Induced Desmin Aggregation in Cellular Models of Desminopathy , 2013, PloS one.

[16]  G. Butler-Browne,et al.  Viral-mediated expression of desmin mutants to create mouse models of myofibrillar myopathy , 2013, Skeletal Muscle.

[17]  S. Strelkov,et al.  Desminopathies: pathology and mechanisms , 2012, Acta Neuropathologica.

[18]  U. Aebi,et al.  Atomic structure of the vimentin central α-helical domain and its implications for intermediate filament assembly , 2012, Proceedings of the National Academy of Sciences.

[19]  Zhigang Xue,et al.  Desmin mutations in the terminal consensus motif prevent synemin-desmin heteropolymer filament assembly. , 2011, Experimental cell research.

[20]  M. Omary,et al.  Keratin Hypersumoylation Alters Filament Dynamics and Is a Marker for Human Liver Disease and Keratin Mutation* , 2010, The Journal of Biological Chemistry.

[21]  H. Westerblad,et al.  Mice expressing L345P mutant desmin exhibit morphological and functional changes of skeletal and cardiac mitochondria , 2008, Journal of Muscle Research and Cell Motility.

[22]  Andreas J Meyer,et al.  Real-time imaging of the intracellular glutathione redox potential , 2008, Nature Methods.

[23]  H. Chung,et al.  Systemic adaptation to oxidative challenge induced by regular exercise. , 2008, Free radical biology & medicine.

[24]  I. Ferrer,et al.  Oxidative Stress in Desminopathies and Myotilinopathies: A Link between Oxidative Damage and Abnormal Protein Aggregation , 2007, Brain pathology.

[25]  M. A. Odena,et al.  Desmin Is Oxidized and Nitrated in Affected Muscles in Myotilinopathies and Desminopathies , 2007, Journal of neuropathology and experimental neurology.

[26]  J. Armstrong,et al.  Phenotypic patterns of desminopathy associated with three novel mutations in the desmin gene , 2007, Neuromuscular Disorders.

[27]  A. Kaminska,et al.  Restrictive cardiomyopathy with atrioventricular conduction block resulting from a desmin mutation. , 2007, International journal of cardiology.

[28]  J. Holton,et al.  Conspicuous involvement of desmin tail mutations in diverse cardiac and skeletal myopathies , 2007, Human mutation.

[29]  K. Green,et al.  New insights into the molecular basis of desmoplakinand desmin-related cardiomyopathies , 2006, Journal of Cell Science.

[30]  F. Chapon,et al.  Variable pathogenic potentials of mutations located in the desmin alpha‐helical domain , 2006, Human mutation.

[31]  Susan C. Brown,et al.  Disease severity in dominant Emery Dreifuss is increased by mutations in both emerin and desmin proteins. , 2006, Brain : a journal of neurology.

[32]  S. Lukyanov,et al.  Genetically encoded fluorescent indicator for intracellular hydrogen peroxide , 2006, Nature Methods.

[33]  U. Aebi,et al.  Severe muscle disease-causing desmin mutations interfere with in vitro filament assembly at distinct stages. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[34]  N. Sonenberg,et al.  Atrophy of S6K1−/− skeletal muscle cells reveals distinct mTOR effectors for cell cycle and size control , 2005, Nature Cell Biology.

[35]  U. Aebi,et al.  The biology of desmin filaments: how do mutations affect their structure, assembly, and organisation? , 2004, Journal of structural biology.

[36]  I. Ferrer,et al.  A series of West European patients with severe cardiac and skeletal myopathy associated with a de novo R406W mutation in desmin , 2004, Journal of Neurology.

[37]  E. Hoffman.  Desminopathies: Good stuff lost, garbage gained, or the trashman misdirected? , 2003, Muscle & nerve.

[38]  K. Zerres,et al.  On noxious desmin: functional effects of a novel heterozygous desmin insertion mutation on the extrasarcomeric desmin cytoskeleton and mitochondria. , 2003, Human molecular genetics.

[39]  J. Nagle,et al.  Progressive skeletal myopathy, a phenotypic variant of desmin myopathy associated with desmin mutations , 2003, Neuromuscular Disorders.

[40]  Ueli Aebi,et al.  Molecular architecture of intermediate filaments , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[41]  U. Aebi,et al.  Conserved segments 1A and 2B of the intermediate filament dimer: their atomic structures and role in filament assembly , 2002, The EMBO journal.

[42]  S. Langlois,et al.  Structural and functional analysis of a new desmin variant causing desmin‐related myopathy , 2001, Human mutation.

[43]  U. Aebi,et al.  Intermediate filaments and their associates: multi-talented structural elements specifying cytoarchitecture and cytodynamics. , 2000, Current opinion in cell biology.

[44]  S. Reipert,et al.  Association of mitochondria with plectin and desmin intermediate filaments in striated muscle. , 1999, Experimental cell research.

[45]  A. Engel.  Myofibrillar myopathy , 1999, Annals of neurology.

[46]  P. Burch,et al.  Desmin mutation responsible for idiopathic dilated cardiomyopathy. , 1999, Circulation.

[47]  J. Nagle,et al.  Missense mutations in desmin associated with familial cardiac and skeletal myopathy , 1998, Nature Genetics.

[48]  Y. Capetanaki,et al.  Disruption of muscle architecture and myocardial degeneration in mice lacking desmin , 1996, The Journal of cell biology.

[49]  C. Babinet,et al.  Cardiovascular lesions and skeletal myopathy in mice lacking desmin. , 1996, Developmental biology.

[50]  J. Thornton,et al.  Influence of proline residues on protein conformation. , 1991, Journal of molecular biology.

[51]  C. Delcayre,et al.  Storage of phosphorylated desmin in a familial myopathy , 1988, FEBS letters.

[52]  K. Weber,et al.  Intermediate Filaments: Structural Conservation and Divergence , 1985, Annals of the New York Academy of Sciences.

[53]  A. Quintanilha,et al.  Changes in the glutathione status of plasma, liver and muscle following exhaustive exercise in rats , 1985, FEBS letters.

[54]  M. Gottesman,et al.  In vitro assembly of homopolymer and copolymer filaments from intermediate filament subunits of muscle and fibroblastic cells. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[55]  aryline Moulina,et al.  Muscle redox disturbances and oxidative stress as pathomechanisms and therapeutic targets in early-onset myopathies , 2017 .

[56]  M. Beckerle,et al.  Striated muscle cytoarchitecture: an intricate web of form and function. , 2002, Annual review of cell and developmental biology.

[57]  Sergei V Strelkov,et al.  Analysis of alpha-helical coiled coils with the program TWISTER reveals a structural mechanism for stutter compensation. , 2002, Journal of structural biology.

[58]  K. Davies,et al.  HSP70 and other possible heat shock or oxidative stress proteins are induced in skeletal muscle, heart, and liver during exercise. , 1991, Free radical biology & medicine.